C4 Therapeutics Inc. has granted a new employee non-qualified stock options to purchase 85,480 shares of the company’s common stock. The exercise price for these options is set at the closing price of C4 Therapeutics’ common stock on the grant date, January 26, 2026. The options will vest over four years, with 25% vesting on the first anniversary of the employee’s start date and the remaining shares vesting in thirty-six equal monthly installments, contingent on continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. C4 Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9642465) on January 26, 2026, and is solely responsible for the information contained therein.